“Chronic lung disease has plagued our society for years and every day, our team sees firsthand the impact it has on the patients we treat,” Jimmy St. Louis, CEO of Lung Health Institute, formerly known as Lung Institute, said. “We recognize that so much more needs to be done to advance the way chronic lung disease is treated and that’s why we continually evolve to meet the growing needs of our patients.”
Since 1980, more than 4.6 million Americans have died from chronic respiratory disease, according to a recent study published in the Journal of the American Medical Association, which equates to an increase of nearly 31 percent in the span of a few decades.
“For too long, people suffering from chronic lung disease have been left behind,” Jack Coleman, M.D., Lung Health Institute, said. “At Lung Health Institute, we look to bridge the gap between what’s available in terms of treatment for lung disease currently and what’s possible in the future.”
In addition to introducing new programs such as the Anti-Inflammatory Initiative (AI2) designed to increase lung function by reducing systemic inflammation, the Lung Health Institute created an advisory board to guide research efforts aimed at accelerating the advancement of chronic lung disease treatment.
“We’re challenging ourselves to push beyond conventional treatment to give lung disease patients hope for a better future and we’re always in search of the next breakthrough that will revolutionize care,” Dr. Coleman said. “All of our resources are being focused on slowing the progression of lung disease and improving the quality of life for those affected by lung disease.”
Take the next step to find relief. Contact Lung Health Institute today for more information or to schedule a free consultation at 855-882-1292.